DR. JEFF CARROLL AND DR. BETH HOFFMAN JOIN HUNTINGTON’S DISEASE SOCIETY OF AMERICA NATIONAL BOARD OF TRUSTEES
New York, NY (December 3, 2021) — The Huntington’s Disease Society of America (HDSA) is proud to announce that Jeff Carroll, PhD and Beth Hoffman, PhD have been elected to the Society’s National Board of Trustees.
“On behalf of HDSA’s Board of Trustees, we are excited to welcome Dr. Carroll and Dr. Hoffman” said HDSA’s President and CEO Louise Vetter. “They are both established scientific and volunteer leaders in the HD community whose experience will undoubtedly strengthen HDSA’s mission work.”
Dr. Carroll is an Associate Professor in the Behavioral Neuroscience Program and the Department of Psychology at Western Washington University. Dr. Carroll is Co-Founder of HDBuzz.net and continues to serve as the site’s Editor-in-Chief. During his PhD he trained with Michael Hayden (University of British Columbia), his postdoctoral studies were conducted under the supervision of Marcy MacDonald (MGH, Harvard Medical School). As well as conducting research, Dr. Carroll is a member of an HD family and carries the mutation which causes HD.
Dr. Hoffman is the Founder and CEO at Origami Therapeutics, Inc. At Origami, Dr. Hoffman is leveraging lessons learned during 20 years of CNS drug discovery to create a novel, precision medicine approach to treating neurodegenerative diseases by “fixing broken proteins”. Dr. Hoffman served on the Board of Directors at HDSA’s San Diego Chapter and currently serves on the Scientific Advisory Board of the Tau Consortium. Dr. Hoffman received an AB in Molecular Biology from Wellesley College, a PhD in Cell Biology from the Johns Hopkins University and was Chief of the Molecular Pharmacology Unit at the National Institute of Mental Health in Bethesda, Maryland.
For more information about HDSA’s National Board of Trustees, please visit www.HDSA.org/bot.
Huntington’s disease is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain. It deteriorates a person’s physical and mental abilities during their prime working years and has no cure. Every child of a parent with HD has a 50/50 chance of carrying the faulty gene. Today, there are approximately 41,000 symptomatic Americans and more than 200,000 at-risk of inheriting the disease.
The symptoms of HD are described as having ALS, Parkinson’s & Alzheimer’s – simultaneously.
The Huntington’s Disease Society of America is the premier nonprofit organization dedicated to improving the lives of everyone affected by HD. From community services and education to advocacy and research, HDSA is the world’s leader in providing help for today and hope for tomorrow for people with HD and their families.
To learn more about Huntington’s disease and the work of the Huntington’s Disease Society of America, visit www.hdsa.org or call (800)345-HDSA.